NLRP3 and atherosclerosis: By inducing autophagy, atorvastatin reduces the vulnerability of atherosclerosis plaques in mice, inhibits the inflammatory response, and activates the NLRP3 inflammasome, as well as inhibiting foam cell formation and inflammatory cytokine secretion in macrophages stimulated with ox-LDL [156].